US2008166747A1PendingUtilityA1

Biosensor

57
Assignee: UNIV DUKEPriority: Oct 16, 2002Filed: Apr 18, 2007Published: Jul 10, 2008
Est. expiryOct 16, 2022(expired)· nominal 20-yr term from priority
G01N 2333/195G01N 33/54373C12Q 1/001G01N 33/542G01N 33/566
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Biosensors are made by attaching covalently or non-covalently at least one reporter group to one or more specific positions of a bacterial periplasmic binding protein (bPBP). Upon binding of ligand to the biosensor, there is a change in the signal transduced by the reporter group.

Claims

exact text as granted — not AI-modified
1 . A biosensor for ligand, which comprises a glucose binding protein (GBP) and at least one reporter group attached at position 183 of said GBP, wherein binding of glucose in a glucose-binding pocket of said biosensor causes a change in signaling by said reporter group. 
     
     
         2 . The biosensor according to  claim 1 , wherein said GBP is a W183C mutant. 
     
     
         3 - 6 . (canceled) 
     
     
         7 . The biosensor according to  claim 1 , wherein said reporter group is covalently attached. 
     
     
         8 . The biosensor according to  claim 1 , wherein said reporter group is noncovalently attached. 
     
     
         9 . The biosensor according to  claim 1 , wherein said reporter group is a redox cofactor. 
     
     
         10 . The biosensor according to  claim 1 , wherein said reporter group is a fluorophore. 
     
     
         11 . The biosensor according to  claim 1 , wherein said biosensor's standard intensity change (ΔI std ) upon binding of ligand is greater than 0.25. 
     
     
         12 . The biosensor according to  claim 11 , wherein said ΔI std  is greater than 0.9. 
     
     
         13 . The biosensor according to  claim 1 , wherein said biosensor's maximum value of standard ratiometric change (ΔR max ) upon binding of ligand is greater than 1.25. 
     
     
         14 . The biosensor according to  claim 13 , wherein said ΔR max  is greater than 2.5. 
     
     
         15 . (canceled) 
     
     
         16 . A method of detecting presence or absence of glucose in a sample, which comprises: contacting a biosensor according to  claim 1  with said sample under conditions such that said biosensor is able to bind to glucose present in said sample; comparing the signal transduced by said reporter group when said biosensor is contacted with said sample with the signal(s) transduced by said reporter group when said biosensor is contacted with at least one control sample containing a known quantity of glucose; and determining the presence or absence of glucose in said sample from said comparison. 
     
     
         17 . A method of quantitating amount or concentration of glucose in a sample, which comprises: contacting a biosensor according to  claim 1  with said sample under conditions such that said biosensor is able to bind to glucose present in said sample; comparing the signal transduced by said reporter group when said biosensor is contacted with said sample against signals transduced by a series of control samples containing known quantities of glucose; and calculating the quantity of glucose in said sample from said comparison. 
     
     
         18 . A method of assaying for glucose in a sample, which comprises:
 (a) contacting a biosensor according to  claim 1 ;   (b) measuring a ratiometric change (ΔR) for the signal transduced by said reporter group; and   (c) at least detecting or quantitating ligand present in said sample.   
     
     
         19 . The method of  claim 18 , wherein said sample is comprised of a physiological fluid. 
     
     
         20 . The method of  claim 19 , wherein said physiological fluid is selected from the group consisting of blood, interstitial fluid, lavage, perspiration, plasma, saliva, serum, and urine. 
     
     
         21 - 22 . (canceled) 
     
     
         23 . The method of  claim 16 , wherein said sample is comprised of a physiological fluid. 
     
     
         24 . The method of  claim 23 , wherein said physiological fluid is selected from the group consisting of blood, interstitial fluid, lavage, perspiration, plasma, saliva, serum, and urine. 
     
     
         25 . The method of  claim 17 , wherein said sample is comprised of a physiological fluid. 
     
     
         26 . The method of  claim 25 , wherein said physiological fluid is selected from the group consisting of blood, interstitial fluid, lavage, perspiration, plasma, saliva, serum, and urine.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.